100 related articles for article (PubMed ID: 15599929)
1. Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals.
Scholz M; Cinatl J
Med Res Rev; 2005 May; 25(3):331-42. PubMed ID: 15599929
[TBL] [Abstract][Full Text] [Related]
2. Fas and Fas ligand interactions in malignant disease.
Owen-Schaub L; Chan H; Cusack JC; Roth J; Hill LL
Int J Oncol; 2000 Jul; 17(1):5-12. PubMed ID: 10853011
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
5. The Fas signalling pathway and its role in the pathogenesis of cancer.
Houston A; O'Connell J
Curr Opin Pharmacol; 2004 Aug; 4(4):321-6. PubMed ID: 15251123
[TBL] [Abstract][Full Text] [Related]
6. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
7. Fas and FasL in the homeostatic regulation of immune responses.
Lynch DH; Ramsdell F; Alderson MR
Immunol Today; 1995 Dec; 16(12):569-74. PubMed ID: 8579749
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.
Stassi G; Di Felice V; Todaro M; Cappello F; Zummo G; Farina F; Trucco M; De Maria R
Arch Immunol Ther Exp (Warsz); 1999; 47(3):129-33. PubMed ID: 10470438
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
10. The role of Fas ligand in immune privilege.
Green DR; Ferguson TA
Nat Rev Mol Cell Biol; 2001 Dec; 2(12):917-24. PubMed ID: 11733771
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
[TBL] [Abstract][Full Text] [Related]
12. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
[TBL] [Abstract][Full Text] [Related]
14. Detection of Fas ligand in the bovine oviduct.
Bergqvist AS; Killian G; Erikson D; Hoshino Y; Båge R; Sato E; Rodríguez-Martínez H
Anim Reprod Sci; 2005 Mar; 86(1-2):71-88. PubMed ID: 15721660
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cell death in T cells and autoimmunity.
Zhang J; Xu X; Liu Y
Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
[TBL] [Abstract][Full Text] [Related]
16. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
17. [Membrane protein Fas/FasL system in viral infections].
Ma BJ; Hang CS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):94-7. PubMed ID: 12526314
[No Abstract] [Full Text] [Related]
18. Safrole oxide induces apoptosis by up-regulating Fas and FasL instead of integrin beta4 in A549 human lung cancer cells.
Du A; Zhao B; Miao J; Yin D; Zhang S
Bioorg Med Chem; 2006 Apr; 14(7):2438-45. PubMed ID: 16326105
[TBL] [Abstract][Full Text] [Related]
19. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation.
Pearl-Yafe M; Yolcu ES; Yaniv I; Stein J; Shirwan H; Askenasy N
Bioessays; 2006 Feb; 28(2):211-22. PubMed ID: 16435302
[TBL] [Abstract][Full Text] [Related]
20. Fas (CD95)-related apoptosis and rheumatoid arthritis.
Peng SL
Rheumatology (Oxford); 2006 Jan; 45(1):26-30. PubMed ID: 16159946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
